ALLIED PROPERTY AND CASUALTY INSURANCE COMPANY v. BLOODWORTH WHOLESALE DRUGS INC

CourtDistrict Court, M.D. Georgia
DecidedMarch 27, 2024
Docket7:22-cv-00113
StatusUnknown

This text of ALLIED PROPERTY AND CASUALTY INSURANCE COMPANY v. BLOODWORTH WHOLESALE DRUGS INC (ALLIED PROPERTY AND CASUALTY INSURANCE COMPANY v. BLOODWORTH WHOLESALE DRUGS INC) is published on Counsel Stack Legal Research, covering District Court, M.D. Georgia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
ALLIED PROPERTY AND CASUALTY INSURANCE COMPANY v. BLOODWORTH WHOLESALE DRUGS INC, (M.D. Ga. 2024).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE MIDDLE DISTRICT OF GEORGIA VALDOSTA DIVISION

ALLIED PROP. CAS. INS. CO. & : AMICO INS. CO., : : Plaintiffs, : : CASE NO.: 7:22-CV-00113 (WLS) v. : : BLOODWORTH WHOLESALE : DRUGS, INC., : : Defendant. : : ORDER Before the Court are cross-Motions for Summary Judgment by (Doc. 32) Plaintiffs Allied Property & Casualty Insurance Company (“Allied”) and AMCO Insurance Company (“AMCO”) and by Defendant Bloodworth Wholesale Drugs, Inc. (“Bloodworth”) (Doc. 31), both filed on August 28, 2023. RELEVANT BACKGROUND & FACTS The following facts are derived from Plaintiffs’ Complaint, Plaintiffs’ Motion for Summary Judgment, Defendant’s Motion for Summary Judgment, Plaintiffs’ Response in Opposition, Defendant’s Response in Opposition, Plaintiffs’ Reply, Defendant’s Reply, and the Parties joint statement of stipulated facts, and record in this case that have been properly cited to and supported by evidence. Where relevant, the factual summary contains undisputed and disputed facts derived from the pleadings, the materials on the record, and attached exhibits. All evidence, the record, and any inferences arising therefrom are construed in a light most favorable to the nonmoving Party. Defendant Bloodworth is a local pharmacy distributor in Tifton, Georgia, that supplies and distributes generic pharmaceuticals and prescription drugs, including opioids. (Doc. 31-1, at 5). Amid the nationwide opioid crisis, Defendant Bloodworth was named as a defendant1 in twenty-six (26) opioid lawsuits that were initiated between 2017 and 2019 by various county and municipal government entities, hospital organizations, and medical management companies (“underlying opioid lawsuits”). (Doc. 28, at 18–21). All complaints in the underlying opioid lawsuits are similar in nature in that those complaints allege that pharmaceutical distributors, like Bloodworth, failed to monitor for, investigate, report, and stop suspicious orders of opioid medications and that such failure contributed to the opioid crisis. (Doc. 32-1, at 4); (Doc. 14, at 14). In particular, seventeen (17) of the twenty-six (26) complaints allege that plaintiffs are not seeking damages for personal injury or property damage; instead, those plaintiffs seek reimbursement from defendants, like Bloodworth, for costs associated with efforts in eliminating the hazards of the opioid epidemic to public health and safety. (Docs. 14-3; 14-5; 14-14; 14-16; 14-18; 14-21; 14-23). The other nine (9) complaints also describe the plaintiffs’ damages as economic losses, economic harm, or economic costs incurred because of defendants’ marketing and unlawful diversion of prescription opioids. (Docs. 14-17; 14-9; 14-11; 14-12; 14-13; 14-20). Following the commencement of the underlying opioid lawsuits, Defendant Bloodworth reported the litigation to its insurers, Plaintiffs Allied and AMCO, to recover its costs for the lawsuits. From May 31, 2006, to May 31, 2018, Plaintiff Allied had issued to Defendant Bloodworth the following Commercial General Liability insurance policy (“GCL Policy”) for consecutive one-year periods: ACP GLPO 7102204036, ACP GLPO 7112204036, ACP GLPO 7122204036, ACP GLPO 7132204036, ACP GLPO 7142204036, ACP GLPO 7152204036, ACP GLPO 7162204036, ACP GLPO 7172204036, ACP GLPO 7182204036, and ACP GLPO 7192204036. (Doc. 28, Stipulation of Facts, at 1). Subject to all their terms and conditions, the CGL Policy provides limits of liability of $1,000,000 for each occurrence, subject to a general aggregate limit per policy period of $2,000,000. (Id.) During the same time period, Plaintiff AMCO had also issued to Defendant Bloodworth the following Umbrella Liability insurance policy (“Umbrella Policy”) for consecutive one-year periods: ACP CAA 7102204036, ACP CAA 7112204036, ACP CAA 7122204036, ACP

1 Majority of complaints of the underlying opioid lawsuits were initiated in Georgia federal and state courts but have been subsequently transferred to the multi-district litigation in the Northern District of Ohio. (Doc. 14, at 12–14). CAA 7132204036, ACP CAA 7142204036, ACP CAA 7152204036, ACP CAA 7162204036, ACP CAA 7172204036, ACP CAA 7182204036, and ACP CAA 7192204036. (Id. at 1–2). Subject to all of their terms and conditions, the Umbrella Policy provides limits of liability of $5,000,000 for each occurrence per policy period, above the limits of the underlying insurance in the CGL Policy. (Id. at 2). The CGL Policy provides in relevant part: 1. a. We will pay those sums that the insured becomes legally obligated to pay as damages because of ‘bodily injury’. . . to which this insurance applies. We will have the right and duty to defend the insured against any ‘suit’ seeking those damages. However, we will have no duty to defend the insured against any ‘suit’ seeking damages for ‘bodily injury’ or ‘property damage’ to which this insurance does not apply. We may, at our discretion, investigate any ‘occurrence’ and settle any claim or ‘suit’ that may result….

b. This insurance applies to ‘bodily injury’ and ‘property damage’ only if: (1) The ‘bodily injury’ or ‘property damage’ is caused by an ‘occurrence’ that takes place in the ‘coverage territory’;

(2) The ‘bodily injury’ or ‘property damage occurs during the policy period; . . .

(Doc. 28, at 2–4). The CGL Policy defines “bodily injury” as “bodily injury, sickness or disease sustained by a person, including death resulting from any of these at any time.” (Id. at 3). The CGL Policy also defines “occurrence” as “an accident, including continuous or repeated exposure to substantially the same general harmful conditions.” (Id. at 4). Furthermore, the CGL Policy further states that “[d]amages because of ‘bodily injury’ include damages claimed by any person or organization for care, loss of services or death resulting at any time from the ‘bodily injury.’” (Doc. 14-1, at 13, § I.1.(e)). Next, the Umbrella Policy issued by Plaintiff AMCO provides similar language, which states, in relevant part: A.1. . . . we will pay on behalf of the ‘insured’ that part of ‘loss’ covered by this insurance in excess of the total applicable limits of ‘underlying insurance,’ provided the injury or offense takes place during the Policy Period of this policy. The terms and conditions of ‘underlying insurance’ are, with respect to Coverage A, made a part of this policy except with respect to: a. Any contrary provision contained in this policy; or b. Any provision in this policy for which a similar provision is not contained in ‘underlying insurance.’ . . . B.1. . . . we will pay on behalf of the “insured” damages the “insured” becomes legally obligated to pay by reason of liability imposed by law because of “bodily injury”, “property damage”, or “personal and advertising injury” covered by this insurance which takes place during the Policy Period and is caused by an “occurrence”. We will pay such damages in excess of the Retained Limit Aggregate specified in the Declarations or the amount payable by “other insurance,” whichever is greater.

(Doc. 14-2, at 9, §§ A-B). In sum, coverage is available under the CGL and Umbrella Policies (“Policies”) if the allegations in the underlying opioid lawsuit seek “damages because of ‘bodily injury’” within the meaning of the Policies. (Id. at 2). The Policies note that Plaintiffs have “no duty to defend [Defendant Bloodworth] against any ‘suit’ seeking damages for ‘bodily injury’ . . .

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Julio Barreto v. Davie Marketplace, LLC
331 F. App'x 672 (Eleventh Circuit, 2009)
Allen v. Tyson Foods, Inc.
121 F.3d 642 (Eleventh Circuit, 1997)
Elan Pharmaceutical Research Corp. v. Employers Insurance
144 F.3d 1372 (Eleventh Circuit, 1998)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Andrew Vicks v. Correctional Officer FNU Knight
380 F. App'x 847 (Eleventh Circuit, 2010)
Reginald Jones v. UPS Group Freight
683 F.3d 1283 (Eleventh Circuit, 2012)
Nicole Maddox v. Babette Stephens
727 F.3d 1109 (Eleventh Circuit, 2013)
Darby v. Interstate Life & Accident Insurance
130 S.E.2d 360 (Court of Appeals of Georgia, 1963)
Woodmen of the World Life Insurance Society v. Etheridge
154 S.E.2d 369 (Supreme Court of Georgia, 1967)
Shivers Chix v. Georgia Farm Bureau Insurance
258 S.E.2d 208 (Court of Appeals of Georgia, 1979)
Yeomans & Associates Agency, Inc. v. Bowen Tree Surgeons, Inc.
618 S.E.2d 673 (Court of Appeals of Georgia, 2005)
American National Property & Casualty Co. v. Amerieast, Inc.
677 S.E.2d 663 (Court of Appeals of Georgia, 2009)
O'Dell v. St. Paul Fire & Marine Insurance
478 S.E.2d 418 (Court of Appeals of Georgia, 1996)
Lunceford v. Peachtree Casualty Insurance
495 S.E.2d 88 (Court of Appeals of Georgia, 1997)
Presidential Hotel v. Canal Ins. Co.
373 S.E.2d 671 (Court of Appeals of Georgia, 1988)
Auto-Owners Insurance v. Barnes
373 S.E.2d 217 (Court of Appeals of Georgia, 1988)
Payne v. Middlesex Insurance
578 S.E.2d 470 (Court of Appeals of Georgia, 2003)

Cite This Page — Counsel Stack

Bluebook (online)
ALLIED PROPERTY AND CASUALTY INSURANCE COMPANY v. BLOODWORTH WHOLESALE DRUGS INC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/allied-property-and-casualty-insurance-company-v-bloodworth-wholesale-gamd-2024.